businesspress24.com - AgraFlora Organics Reports 2019 German Medical Cannabis Distribution Gross Profits of 47%
 

AgraFlora Organics Reports 2019 German Medical Cannabis Distribution Gross Profits of 47%

ID: 1555248

(firmenpresse) - Vancouver, British Columbia / January 14th, 2020 - AgraFlora Organics International Inc. (AgraFlora or the Company) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased to report the following unaudited 2019 revenues and profit margin of its wholly-owned German subsidiary, Farmako GmbH (Farmako). On January 3, 2020, AgraFlora announced the Company closed its previously announced acquisition of The Good Company GmbH (the Good Company). The Good Company is the parent company of German EU-GDP medical cannabis distributor, Farmako.

Farmako, which started its German wholesale operations with first revenues in March 2019, reported gross revenues of $3,067,668 for the year ended January 1, 2019 to December 31, 2019, including gross margin of 47 per-cent for cumulative gross profits of $1,438,259 during the year.

Farmako is a leading European medical cannabis distributor, headquartered in Frankfurt, Germany, with affiliated companies in the United Kingdom, Luxembourg and Denmark. Farmako''s German distribution network extends over circa 20,000 pharmacies and comprises an aggregate patient population of over 100,000 unique individuals.

About AgraFlora Organics International Inc.

AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It owns an indoor cultivation operation in London, ON and is a joint venture partner in Propagation Services Canada Inc. and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The Company is also retrofitting a 51,500-square-foot good manufacturing practice (GMP) edibles manufacturing facility in Winnipeg, Manitoba. AgraFlora has a successful record of creating shareholder value and is actively pursuing other opportunities within the cannabis industry. For more information please visit: www.agraflora.com.

ON BEHALF OF THE BOARD OF DIRECTORS




Brandon Boddy
Chairman & CEO
T: (604) 398-3147

For additional information:

AgraFlora Organics International Inc.
Tim McNulty
E: ir(at)agraflora.com
T: (800) 783-6056

For French inquiries:
Remy Scalabrini, Maricom Inc.
E: rs(at)maricom.ca
T: (888) 585-MARI

The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release.

Forward-looking Information Cautionary Statement

Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Companys control. There are no assurances that the business plans for AgraFlora Organics described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management''s estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Companys filings with Canadian securities regulators, which are available at www.sedar.com.

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:





PresseKontakt / Agentur:



Bereitgestellt von Benutzer: irw
Datum: 15.01.2020 - 01:52 Uhr
Sprache: Deutsch
News-ID 1555248
Anzahl Zeichen: 11265

contact information:
Contact person:
Town:

Wien


Phone:

Kategorie:

Business News


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 310 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"AgraFlora Organics Reports 2019 German Medical Cannabis Distribution Gross Profits of 47%

"
steht unter der journalistisch-redaktionellen Verantwortung von

AgraFlora Organics International Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von AgraFlora Organics International Inc.



 

Who is online

All members: 10 568
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 93


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.